4//SEC Filing
D ALONZO THOMAS 4
Accession 0001209191-13-022184
CIK 0001009356other
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 6:18 PM ET
Size
9.6 KB
Accession
0001209191-13-022184
Insider Transaction Report
Form 4
D ALONZO THOMAS
Director
Transactions
- Award
Common Stock
2013-04-18$48.70/sh+4,110$200,157→ 88,564 total
Holdings
- 1,080(indirect: By Trust)
Common Stock
- 6,500(indirect: By Spouse)
Common Stock
- 260(indirect: By LP)
Common Stock
- 22,500
Option to Buy Common Stock
Exercise: $18.87Exp: 2014-06-17→ Common Stock (22,500 underlying) - 15,000
Option to Buy Common Stock
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]Represents a restricted stock award which vests in its entirety on the earlier of July 1, 2014 or immediately prior to the 2014 Annual Stockholder meeting, subject to continued service as a director.
- [F2]The shares are held by the Rachel L. D'Alonzo Rev Trust U/A DTD 10/24/2001 for which the Reporting Person serves as co-trustee.
- [F3]Options are 100% vested.
Documents
Issuer
SALIX PHARMACEUTICALS LTD
CIK 0001009356
Entity typeother
Related Parties
1- filerCIK 0001212667
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 6:18 PM ET
- Size
- 9.6 KB